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Evaluating Screening Policies for Diabetic Retinopathy:  
A Simulation Approach
Background
Diabetic retinopathy (DR) is the leading cause of blindness in American Adults
and the most common diabetic eye disease. More than 60% of patients with type
2 diabetes and more than 90% of patients with type 1 diabetes will develop DR
within 20 years of diagnosis [1]. Regular and timely screening examinations are
crucial as early treatment can prevent up to 98% of DR-related vision loss [2].
Unfortunately, only 30% to 60% of the patients are screened on a yearly basis [3].
The current clinical screening exams are time-consuming, inconvenient, and
costly, leading to such low compliancerates.
In the last decade, teleretinal screening has
received increasing attention as an inexpensive and
convenient screening technique. Telescreening
facilities use cameras with simple functions to
obtain retinal images, which are then electronically
sent to specialists. Due to its accessibility,
telescreening is considered a viable supplementary
exam. However, there is a lack of quantitative
understanding about the right balance between
teleretinal and in-clinic exams and how this
knowledge can help determine an optimal DR
screening policy for diabeticpatients.
Methodology
• The primary method used for our analysis was discrete eventsimulation
• Two different types of measures were used toevaluate screening policies:
(1) Quality-adjusted life years(QALYs)
(2) Cost
• Screening accuracy data from the Harris Health teleretinal screening program  
was collected
• Clinical literature was used to define a base patient: African American, 40-year  
old male
• A Markov Chain was modeled where each state represents a different disease
level for eachpatient:
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• A simulation model was developed based on the  
Markov chain, where five different screeningpolicies  
were simulated for furtherevaluation:
0 = NoDR (No DR)
1 = NPDR (Non-Proliferative DR)  
2 = PDR (Proliferative DR)
3 =Blindness
4 =Death
P00 = 1-(P01+P04)  
P01 = 0.065
P04 = ADP(Age)*1.8  
P11 = 1-(P12+P14)  
P12 = 0.116
P14 = ADP(Age)*1.36
P22= 1-(P23+P24)  
P23 = 0.09





1. Annual teleretinal screening (AnnualT)
2. Biennial teleretinal screening (BiennialT)
3. Teleretinal/In-clinic alternate screening (TCAlternate)
4. Annual in-clinic screening (Annual C)
5. Biennial in-clinic screening (Biennial C)
• Sensitivity analysis was conducted to compare the
screening policies based on various factors,
including screening costs, accuracy, and initial
patient probabilities
Conclusion
For the base population, annual telescreening is the
most cost-effective screening policy out of the five
candidate policies in terms of the average cost per
QALY. Sensitivity analysis results indicate that benefits
of annual telescreening can increase with improved
teleretinal imaging technology and lower screening
costs. However, for patients with higher probability of
having DR, annual in-clinic screening is the best option
due to its ability to accurately detect the disease
despite the high cost. This study provides valuable
insights into the design of a cost-effective DR
screening program, especially for patients with low
socioeconomic status and limited access to eyecare.
Future Work
• Add post-treatment DRprogression
• Implement optimization as a second step to find
the optimal screening schedule for each patient
that enters the system in order to provide
personalized screening recommendations
• Incorporate patient adherence rates in the model
and analyze the role of telescreening to address
patient non-adherence
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Research Objectives
• Develop a simulation model that mimics the progression of DR and captures
the impact of both in-clinic and teleretinal screening on patients’ health
benefit and spending
• Conduct cost-effectiveness analysis for different screening policies utilizing
teleretinal and in-clinic screening technologies to find the optimal screening
policy for patients
Simulation model that incorporates different actions taken ineach policy
Results
Sensitivity analysis 1:
Varying cost of telescreening vs. Average Cost ($)/QALY  
obtained by each screeningpolicy
Sensitivity analysis 2:
Varying patients’  initial probability of No DR vs.  
Average Cost/QALY obtained by each screening policy
Sensitivity analysis 3:
Varying true positive and true negative rates of
telescreening vs. Average Cost/QALY obtained by each
screening policy
Sensitivity analysis 4:
Varying true positive and true negative rates of
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